Announcements
Home ⟩ Insights
Insights
beverage

5 min read • April 20, 2026
Colorado’s New THC Beverage Bill Could Set a National Model

3 min read • April 13, 2026
Mayor Backed Bill Would Let D.C. Breweries And Distilleries Produce Medical Cannabis Beverages

min read • April 9, 2026
California Bill Could Wipe Out Most Cannabis Beverages, Industry Warns

3 min read • April 9, 2026
Edibles.com Opens First Flagship Store In Atlanta As Hemp Retail Moves Offline

4 min read • March 25, 2026
Alcohol Industry Rushes to Save Hemp THC Drinks From Federal Ban

4 min read • March 12, 2026
LEVIA Returns to Founder Control Following Massachusetts Regulatory Approval

3 min read • February 17, 2026
The Case For Low Dose As The Mass Market

3 min read • February 17, 2026
Cornbread Hemp Adds Lagunitas Brewing Veterans To Advise Expansion of Beverage Operations

5 min read • February 12, 2026
Terpene‑Infused Beverages Are Emerging as a Compliant Alternative to Cannabis Drinks
Latest Headlines
View All
4 min read • April 28, 2026
Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck
3 min read • April 28, 2026
This Cannabis Giant Plans Nevada Registration, Here’s What Shareholders And Investors Need To Know
2 min read • April 28, 2026
TerrAscend Extends Cash Flow Streak To 15 Quarters As Growth Returns, Shares Pop
4 min read • April 27, 2026
DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know
4 min read • April 27, 2026
Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect
4 min read • April 27, 2026
EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan
min read • April 27, 2026
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
min read • April 27, 2026
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
min read • April 27, 2026
Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities
min read • April 27, 2026
Astec Announces Quarterly Dividend
min read • April 27, 2026
Près de 3 Canadiens sur 10 n’ont pas encore produit leur déclaration de revenus, alors que la date limite approche à grands pas; plus d’un sur 10 affirme qu’il manquera l’échéance, révèle une nouvelle étude de H&R Block
min read • April 27, 2026
Yukon Metals Options Copper-Gold Project from Renowned Yukon Prospector Ryan Burke, Solidifying Position in Emergent Birch District
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
Cannabis
CNBC
Commodities
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
Hot
Initiation
Insider Trades
Insurance
Interview
Intraday Update
IPOs
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
Top Stories
Topics
Trading Ideas
Travel
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.
